0e432d77-487c-4e8d-9e90-434c45e67be6.png

Global cannabis market poised for 1,000% growth to $140b report predicts.

Aphria signals international intention after acquiring Nuuvera.

Greece plans to tackle domestic unemployment with cannabis production.

Vegetable growers look to cannabis farms for cash crops.

Israeli medical cannabis company proposes joint venture with Canadian company.

Firms look to invest in Malta as government eyes up new cannabis legislation.

ed56dedb-5912-421e-84e3-e0151978fefd (1).png

GW Pharmaceuticals hopes FDA will sign approval for Epidolex.

Legitimate crops to replace Albania’s cannabis farms.

Dutch farmers call for government clamp down on illegal cannabis farms.

First cannabis club in UK backed by local police.

1c862232-d6f2-40c1-8bc8-c207a645b1d5.png
a14d5148-b3e5-49ba-b168-b5c4dd10a166.png

Cannabis Europa, a conference dedicated to shaping the future of medical cannabis in Europe, will take place on 22nd May at the Barbican in London.

Enquiries on early bird tickets, speaking and sponsorship opportunities are available on the website.

4d762e56-bd4b-46e2-9c51-f2d6b47bf71c.png

CULTIVATION LAWS PROHIBITING CANNABIS TREATMENTS IN SLOVENIA

Cannabis is regularly or occasionally used by 15 percent of Slovenian population and it’s estimated that 30,000 citizens self-medicate using cannabis extracts. However, only 160 patients choose to do so legally - via the legally approved synthetic imports.

As part of the Prohibition Partners European Country Review, we examine why so many Slovenian patients choose to self-medicate and how the state is constraining the cannabis industry in Slovenia.